Neutralization: To yield one-half maximal inhibition [ND50] of the biological activity of Human TRAIL/Apo2L (10 ng/ml), a concentration of 0.30-0.60 ug/ml of this antibody is required. ELISA: In a sandwich ELISA (assuming 100 ul/well), a concentration of 2-4 ug/ml of this antibody will detect at least 500 pg/ml of recombinant human sTRAIL/APO2L when used with biotinylated antigen affinity purified anti-human sTRAIL/APO2L (
LS-C104497) as the detection antibody at a concentration of approximately 1-2 ug/ml. Western Blot: To detect Human sTRAIL/Apo2L by Western Blot analysis this antibody can be used at a concentration of 0.25-0.50 ug/ml. Used in conjunction with compatible secondary reagents the detection limit for recombinant Human sTRAIL/Apo2L is 0.25-1 ng/lane, under reducing or non-reducing conditions.